Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation von Croteau, David, Tobenkin, Anne, Brinker, Allen, Kortepeter, Cindy M

Volltext

Expanding spectrum of opportunistic infections associated with dimethyl fumarate von Kim, Tiffany, Croteau, David, Brinker, Allen, Jones, David E, Lee, Paul R, Kortepeter, Cindy M

Volltext

Reporting Adverse Events for Cannabis to the FDA von Hines, Michelle C, Harinstein, Lisa M, Kortepeter, Cindy M

Volltext

Immune-mediated colitis associated with ocrelizumab: A new safety risk von Kim, Tiffany, Brinker, Allen, Croteau, David, Lee, Paul R, Baldassari, Laura E, Stevens, Jessica, Hughes, Alice, Tomaino, Juli, deFonseka, Arushi, Altepeter, Tara, Kortepeter, Cindy M

Volltext

Hemophagocytic lymphohistiocytosis associated with the use of lamotrigine von Kim, Tiffany, Kulick, Corrinne G, Kortepeter, Cindy M, Brinker, Allen, Waldron, Peter

Volltext

Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab von Croteau, David, Flowers, Charlene, Kulick, Corrinne G, Brinker, Allen, Kortepeter, Cindy M

Volltext

An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System von Marwitz, Kathryn, Jones, S. Christopher, Kortepeter, Cindy M., Dal Pan, Gerald J., Muñoz, Monica A.

Volltext

Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility von Muñoz, Monica A., Dal Pan, Gerald J., Wei, Yu-Jung Jenny, Delcher, Chris, Xiao, Hong, Kortepeter, Cindy M., Winterstein, Almut G.

Volltext

Liver injury associated with dimethyl fumarate in multiple sclerosis patients von Muñoz, Monica A, Kulick, Corrinne G, Kortepeter, Cindy M, Levin, Robert L, Avigan, Mark I

Volltext

Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance von Harinstein, Lisa, Kalra, Dipti, Kortepeter, Cindy M., Muñoz, Monica A., Wu, Eileen, Dal Pan, Gerald J.

Volltext

Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration von Muñoz, Monica A., Delcher, Chris, Dal Pan, Gerald J., Kortepeter, Cindy M., Wu, Eileen, Wei, Yu‐Jung Jenny, Xiao, Hong, Winterstein, Almut G

Volltext

Response to: Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy in associati... von Nevo, Ofir N, Brinker, Allen D, Diak, Ida-Lina, Kortepeter, Cindy M

Volltext

Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports von Pham, Phuong, Cheng, Carmen, Wu, Eileen, Kim, Ivone, Zhang, Rongmei, Ma, Yong, Kortepeter, Cindy M., Muñoz, Monica A.

Volltext

Evaluation of a natural language processing tool for extracting gender, weight, ethnicity, and race in the US food and drug administration adverse event reporting system von Dang, Vivian, Wu, Eileen, Kortepeter, Cindy M., Phan, Michael, Zhang, Rongmei, Ma, Yong, Muñoz, Monica A.

Volltext

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance von Misu, Takashi, Kortepeter, Cindy M., Muñoz, Monica A., Wu, Eileen, Dal Pan, Gerald J.

Volltext

Drug-risk communication to pharmacists: Assessing the impact of risk-minimization strategies on the practice of pharmacy von Lee, Lauren Y., Kortepeter, Cindy M., Willy, Mary E., Nourjah, Parivash

Volltext

Mitoxantrone treatment of multiple sclerosis: safety considerations von Pratt, Robert G, Boehm, Gerard A, Kortepeter, Cindy M, Racoosin, Judith A

Volltext

Lamotrigine and aseptic meningitis von SIMMS, Kelley M, KORTEPETER, Cindy, AVIGAN, Mark

Volltext

Renal failure associated with the use of celecoxib and rofecoxib von AHMAD, Syed R, KORTEPETER, Cindy, BRINKER, Allen, MIN CHEN, BEITZ, Julie

Volltext

Labeling and Drug Safety Communication Approaches to Loperamide Abuse von Woronow, Daniel, MD, Swank, Kimberley A., PharmD, Wu, Eileen, PharmD, Kortepeter, Cindy, PharmD, Levin, Robert L., MD

Volltext